Navigation Links
US BioDesign Relocation Expands Manufacturing Capabilities
Date:7/23/2013

QUAKERTOWN, Pa., July 23, 2013 /PRNewswire-iReach/ -- QUAKERTOWN, Pennsylvania (July 23, 2013) -- US BioDesign, LLC, a global leader in the production of biomedical textile structure components, today announced the relocation of its current manufacturing headquarters (in Perkasie, PA) to a business campus in Quakertown, PA.  At its new location, the company will develop and manufacture biomedical textile components for medical device manufacturers. The new facility encompasses clean room technology, state-of-the-art manufacturing equipment, increased capacity, and dedicated developmental support, in addition to expanded office space.

According to US BioDesign President and Founder Tom Molz, the company's relocation supports essential, short-term business goals and is key to advancing longer-term growth strategies.  "This is an exciting time for US BioDesign. With multiple developmental projects nearing commercialization, this is the right time for us to expand.  Our business is growing rapidly and we've got a lot of momentum moving forward. We're excited about the future," he said.

Comprised of surgical, cardiovascular, neurovascular, neurological, orthopedic, general medical and other devices, the global medical device industry has experienced significant growth over the last five years and is expected to continue. Neurology devices are predicted to post the fastest growth, expected to expand by 6.1% per year.

"Our decision to relocate was made in response to listening to our customers and our evaluation of where we see the industry moving, based on current and emerging industry trends. This move gives us the technological bandwidth and expanded manufacturing capabilities and capacity that we need to respond with agility and flexibility as the needs of our customers evolve," commented Mr. Molz.

US BioDesign Founder Tom Molz has driven discovery and innovation within the medical/biomedical textiles and implantable fabrics for medical devices industry for more than 20 years, and has been involved with biomedical textile developments in virtually all areas of the medical device industry. US BioDesign is the second biomedical manufacturing company founded by Mr. Molz.

About US BioDesign:

US BioDesign is a global leader in the development and manufacture of biomedical textile structure components for medical devices across the cardiovascular, neurological and general surgery medical device segments of the health care industry.  US BioDesign draws upon deep biomedical engineering expertise and an unparalleled understanding of medical device construct development involving polymeric and/or metallic raw materials to deliver elegant and efficient engineering solutions and commercial development support.

Contact:

US BioDesign, LLC


Tom Molz, President


P: 267- 450-8860, x102

E: tmolz@usbiodesign.com

www.usbiodesign.com

###

Media Contact: Trish Boppert, Boppert Communications, 215/275-5349, tboppert@verizon.net

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE US BioDesign
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Collegium Pharmaceutical Announces Relocation to Massachusetts
2. Kibow Biotech Marks Its Continued Growth with Relocation to Larger Facilities
3. BME Expands Surgeon Advisory Board
4. Senior Home Care Expands In-Home Telemonitoring to Serve Patients in The Villages, Fla. Area
5. Boehringer Ingelheim Renews and Expands License to NextBio Research Platform
6. Blue Sky BioServices Expands its Executive Team - Announces Appointment of Ted Marple as President and CEO
7. MicroConstants Expands Biomarker Testing and Analysis Services for Preclinical and Clinical Diagnostic Research
8. Grunenthal Expands Use of BioClinicas Next Generation Trident IWR/IVR for Global Trial
9. Amerivet Solutions Expands to Manufacture Complex Metal Designs
10. Life Technologies Expands Range of Stem Cell Reprogramming Solutions
11. QIAGEN Significantly Expands its Offering of Assay Panels for Next-generation Sequencing (NGS) Complemented by Ingenuity Analysis and Interpretation Capabilities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the ... AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in ... topics including advance care planning, healthcare costs and patient and family engagement. , ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
Breaking Medicine News(10 mins):